Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndromeMargot A. Cousin, Amy Kritzer, Damaris N. Lorenzo et al.|Nature Genetics|2021Cited by 110
Early initiation of enzyme replacement therapy in classical Fabry disease normalizes biomarkers in clinically asymptomatic pediatric patientsAmy Kritzer, Olaf A. Bodamer, Aishwarya Siddharth et al.|Molecular Genetics and Metabolism Reports|2019Cited by 12
Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathyEmily Banks, Hane Lee, Fowzan S. Alkuraya et al.|Nature Communications|2024Cited by 5
Pathogenic <i>SPTBN1</i> variants cause a novel autosomal dominant neurodevelopmental syndromeMargot A. Cousin, Ingrid M.B.H. van de Laar, Keith A. Breau et al.|medRxiv|2020Cited by 3
Loss of symmetric cell division of apical neural progenitors drives <i>DENND5A</i> -related developmental and epileptic encephalopathyEmily Banks, Hane Lee, Vincent Francis et al.|medRxiv|2022Cited by 0